COVID-19 and children

Author:

Pierce Carl A.1,Herold Kevan C.2,Herold Betsy C.13,Chou Janet45,Randolph Adrienne467,Kane Binita8,McFarland Sammie9,Gurdasani Deepti10,Pagel Christina11,Hotez Peter1213141516,Cobey Sarah17,Hensley Scott E.18

Affiliation:

1. Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, USA.

2. Departments of Immunobiology and of Medicine, Yale School of Medicine, New Haven, CT, USA.

3. Department of Pediatrics, Albert Einstein College of Medicine, Children’s Hospital at Montefiore, Bronx, NY, USA.

4. Division of Immunology, Department of Pediatrics, Boston Children’s Hospital, Boston, MA, USA.

5. Department of Pediatrics, Harvard Medical School, Boston, MA, USA.

6. Department of Anesthesiology, Critical Care, and Pain Medicine, Boston Children’s Hospital, Boston, MA, USA.

7. Department of Anaesthesia, Harvard Medical School, Boston, MA, USA.

8. Manchester University Foundation Trust and School of Biological Sciences, University of Manchester, Manchester, UK.

9. Long Covid Kids & Friends Charity, Crowhurst, UK.

10. William Harvey Research Institute, Queen Mary University of London, London, UK.

11. Clinical Operational Research Unit, University College London, London, UK.

12. Texas Children’s Hospital Center for Vaccine Development, Departments of Pediatrics and Molecular Virology and Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA.

13. Department of Biology, Baylor University, Waco, TX, USA.

14. Hagler Institute for Advanced Study, Texas A&M University, College Station, TX, USA.

15. Scowcroft Institute of International Affairs, Texas A&M University, College Station, TX, USA.

16. James A. Baker III Institute for Public Policy, Rice University, Houston, TX, USA.

17. Department of Ecology and Evolution, University of Chicago, Illinois, USA.

18. Department of Microbiology, University of Pennsylvania, Philadelphia, PA, USA.

Abstract

There has been substantial research on adult COVID-19 and how to treat it. But how do severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections afflict children? The COVID-19 pandemic has yielded many surprises, not least that children generally develop less severe disease than older adults, which is unusual for a respiratory disease. However, some children can develop serious complications from COVID-19, such as multisystem inflammatory syndrome in children (MIS-C) and Long Covid, even after mild or asymptomatic COVID-19. Why this occurs in some and not others is an important question. Moreover, when children do contract COVID-19, understanding their role in transmission, especially in schools and at home, is crucial to ensuring effective mitigation measures. Therefore, in addition to nonpharmaceutical interventions, such as improved ventilation, there is a strong case to vaccinate children so as to reduce possible long-term effects from infection and to decrease transmission. But questions remain about whether vaccination might skew immune responses to variants in the long term. As the experts discuss below, more is being learned about these important issues, but much more research is needed to understand the long-term effects of COVID-19 in children.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3